Cite
HARVARD Citation
Borgo, C. et al. (n.d.). Aberrant signalling by protein kinase CK2 in imatinib‐resistant chronic myeloid leukaemia cells: Biochemical evidence and therapeutic perspectives. Molecular oncology. 7 (6), pp. 1103-1115. [Online].